A CMR prospective survey on heart iron and function in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
25 May 2017 (00:00 - 00:00)
Organised by:
About the speaker

Toscana Gabriele Monasterio Foundation, Pisa (Italy)
12 More presentations in this session
Mr S. CRANDON (Oxford, GB)
Doctor W. Moody (Birmingham, GB)
Doctor M. Nolan (Hobart, AU)
Professor L. Zhong (Singapore, SG)
Access the full session
The Event
EuroCMR 2017
25 May - 27 May 2017
